Arcus Biosciences (RCUS) Research & Development: 2017-2025
Historic Research & Development for Arcus Biosciences (RCUS) over the last 8 years, with Sep 2025 value amounting to $141.0 million.
- Arcus Biosciences' Research & Development rose 14.63% to $141.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $503.0 million, marking a year-over-year increase of 14.32%. This contributed to the annual value of $448.0 million for FY2024, which is 31.76% up from last year.
- Arcus Biosciences' Research & Development amounted to $141.0 million in Q3 2025, which was up 1.44% from $139.0 million recorded in Q2 2025.
- Arcus Biosciences' 5-year Research & Development high stood at $141.0 million for Q3 2025, and its period low was $50.6 million during Q4 2021.
- For the 3-year period, Arcus Biosciences' Research & Development averaged around $108.2 million, with its median value being $109.0 million (2024).
- In the last 5 years, Arcus Biosciences' Research & Development soared by 186.87% in 2021 and then fell by 8.11% in 2022.
- Arcus Biosciences' Research & Development (Quarterly) stood at $50.6 million in 2021, then skyrocketed by 58.14% to $80.0 million in 2022, then climbed by 16.25% to $93.0 million in 2023, then grew by 8.60% to $101.0 million in 2024, then rose by 14.63% to $141.0 million in 2025.
- Its Research & Development stands at $141.0 million for Q3 2025, versus $139.0 million for Q2 2025 and $122.0 million for Q1 2025.